Valuation Finch Therapeutics Group, Inc.

Stocks

Delayed OTC Markets Other stock markets 15:57:27 2026-07-02 EDT			5-day change	1st Jan Change
10.50 ^USD	+3.96%		+7.69%	-22.15%

04-26	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	473.4	22.99	5.797
Change	-	-95.14%	-74.79%
Enterprise Value (EV) ¹	345.9	4.311	10.8
Change	-	-98.75%	150.5%
P/E	-6.72x	-0.2x	-0.08x
PBR	2.34x	0.24x	0.25x
PEG	0.1x	-0x	0x
Capitalization / Revenue	25.5x	26.7x	54.2x
EV / Revenue	18.7x	5.01x	101x
EV / EBITDA	-6x	-0.05x	-0.33x
EV / EBIT	-5.77x	-0.05x	-0.32x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-44.51	-72.12	-46.59
Distribution rate	-	-	-
Net sales ¹	18.53	0.861	0.107
EBITDA ¹	-57.68	-89.61	-32.48
EBIT ¹	-59.98	-95.12	-34
Net income ¹	-58.16	-114.6	-74.75
Net Debt ¹	-127.4	-18.68	5.002
Reference price ²	299.10	14.40	3.61
Nbr of stocks (in thousands)	1,583	1,597	1,606
Announcement Date	3/31/22	3/23/23	3/25/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FINCH THERAPEUTICS GROUP, INC.	-	-	-	-	16.86M
LONZA GROUP AG	34.02x	5.98x	18.5x	0.96%	49.15B
REVOLUTION MEDICINES, INC.	-23.69x	348.44x	-22.41x	-.--%	40.23B
IQVIA HOLDINGS INC.	25.19x	2.79x	12.06x	-.--%	34.55B
BEONE MEDICINES AG	44.97x	4.49x	28.67x	-.--%	33.09B
CELLTRION, INC.	29.73x	7.68x	19.76x	0.42%	25.19B
MEDPACE HOLDINGS, INC.	32.72x	5.32x	24.23x	-.--%	15.92B
EUROFINS SCIENTIFIC SE	24.01x	2.04x	8.98x	1.11%	13.83B
ICON PUBLIC LIMITED COMPANY	24.5x	1.94x	11.76x	-.--%	13.26B
Average	23.93x	47.34x	12.69x	0.31%	25.03B
Weighted average by Cap.	22.22x	66.11x	11.26x	0.33%